Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Synlogic Inc (NQ: SYBX )

1.430 +0.030 (+2.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Synlogic Inc

< Previous 1 2 3 4 5 6 Next >
Life Sciences Virtual Investor Forum Agenda Announced for March 9th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Synlogic To Present Three Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
From Synlogic, Inc.
Via GlobeNewswire
Synlogic Announces Participation in Upcoming Investor and Industry Conferences
From Synlogic, Inc.
Via GlobeNewswire
Synlogic Touts Positive Data From Rare Inherited Disorder Trial, Pivotal Study To Start Next Year
Via Benzinga
Recap: Synlogic Q2 Earnings
  Synlogic (NASDAQ:SYBX) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's the final day of trading this week and we're checking in on the biggest pre-market stock movers for Friday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Synlogic Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria (PKU)
From Synlogic, Inc.
Via GlobeNewswire
Sidoti's January Micro-Cap Conference
Via ACCESSWIRE
Synlogic Provides Corporate Update and Outlook for 2023
From Synlogic, Inc.
Via GlobeNewswire
Synlogic Announces Appointment of Dr. Dave Hava as Head of Research and Development
From Synlogic, Inc.
Via GlobeNewswire
Synlogic's Experimental Drug Lowers Urinary Oxalate In Gastric Bypass Patients
Synlogic Inc's (NASDAQ: SYBX) SYNB8802 has demonstrated proof of concept through a clinically significant lowering of urinary oxalate in a Phase 1b study in patients with a history of gastric bypass... 
Via Benzinga
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
From Synlogic, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update
From Synlogic, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
  On Monday, 79 companies reached new 52-week lows. 
Via Benzinga
BP To Rally Around 22%? Plus This Analyst Predicts $47 For YETI
  Piper Sandler boosted the price target on BP p.l.c. (NYSE: BP) from $37 to $40. BP shares rose 1.9% to close at $32.95 on Thursday. 
Via Benzinga
Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update
From Synlogic, Inc.
Via GlobeNewswire
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
From Synlogic, Inc.
Via GlobeNewswire
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
FDA Grants Fast Track Status To Synlogic's Rare Genetic Disorder Drug
Synlogic, Inc. (NASDAQ: SYBX) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its drug candidate SYNB1353 for the potential treatment of homocystinuria... 
Via Benzinga
What Is Going on With Ginkgo Bioworks (DNA) Stock Today?
DNA stock and other small biotech plays are rising on speculation about drugs like its candidate against gout. 
Via InvestorPlace
Why Ginkgo Bioworks Stock Is Soaring Today
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Thursday after Synlogic Inc (NASDAQ: SYBX) announced a new drug candidate for the treatment of gout, which is being developed in... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 92 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.